PT1575483E - Bactérias gram negativas atenuadas - Google Patents

Bactérias gram negativas atenuadas Download PDF

Info

Publication number: PT1575483E
Authority: PT; Portugal
Prior art keywords: gram negative; negative bacteria; bacterium; attenuated gram; mutant
Prior art date: 2002-04-05

Application number

PT03719577T

Other languages

English (en)

Inventor

Jacqueline Elizabeth Shea

Robert Graham Feldman

Helen Rachel Crooke

Sylvain Gabriel Coutebroze

Francois-Xavier Legros

Original Assignee

Merial Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-05

Filing date

2003-04-04

Publication date

2011-09-08

2003-04-04 Application filed by Merial Llc filed Critical Merial Llc

2011-09-08 Publication of PT1575483E publication Critical patent/PT1575483E/pt

Links

241000894006 Bacteria Species 0.000 title abstract 4
230000002238 attenuated effect Effects 0.000 title abstract 2
230000035772 mutation Effects 0.000 abstract 2
239000002773 nucleotide Substances 0.000 abstract 2
125000003729 nucleotide group Chemical group 0.000 abstract 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1
230000001018 virulence Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Tropical Medicine & Parasitology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT03719577T 2002-04-05 2003-04-04 Bactérias gram negativas atenuadas PT1575483E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US37028202P	2002-04-05	2002-04-05
US10/406,686 US7449178B2 (en)	2002-04-05	2003-04-03	Attenuated gram negative bacteria

Publications (1)

Publication Number	Publication Date
PT1575483E true PT1575483E (pt)	2011-09-08

Family

ID=29254405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT03719577T PT1575483E (pt)	2002-04-05	2003-04-04	Bactérias gram negativas atenuadas

Country Status (16)

Country	Link
US (3)	US7449178B2 (pt)
EP (1)	EP1575483B1 (pt)
JP (1)	JP4338528B2 (pt)
KR (1)	KR101037566B1 (pt)
CN (2)	CN102864090A (pt)
AT (1)	ATE518955T1 (pt)
AU (2)	AU2003223447C1 (pt)
BR (1)	BRPI0309001B1 (pt)
CA (1)	CA2481186C (pt)
CO (1)	CO5640065A1 (pt)
ES (1)	ES2371498T3 (pt)
HK (1)	HK1078271A1 (pt)
MX (1)	MXPA04009730A (pt)
NZ (1)	NZ535993A (pt)
PT (1)	PT1575483E (pt)
WO (1)	WO2003086277A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0796341T3 (da) *	1994-12-09	1999-06-14	Imp College Innovations Ltd	Identifikation af gener, som tillader tilpasning af en mikroorganisme til en særlig omgivelse
DE69942925D1 (de) *	1998-09-04	2010-12-16	Emergent Product Dev Uk Ltd	Abgeschwächte Salmonella SP12 Mutante als Antigen-Träger.
GB9910812D0 (en) *	1999-05-10	1999-07-07	Microscience Ltd	Vaccine composition
US7449178B2 (en) *	2002-04-05	2008-11-11	Merial Limited	Attenuated gram negative bacteria
ATE470674T1 (de) *	2002-04-05	2010-06-15	Merial Sas	Abgeschwächte gramnegative bakterien
SI1638598T1 (sl) *	2003-07-02	2007-04-30	Biotechnology Res & Dev	Acapsularna bakterija p. multocida mutanta z delecijo gena hyae
WO2006122586A1 (en)	2004-12-22	2006-11-23	Intervet International B.V.	Pasteurella multocida vaccine
WO2009158240A1 (en)	2008-06-16	2009-12-30	Emergent Product Development Uk Limited	Salmonella vectored vaccines against chlamydia and methods of use
US8917497B2 (en) *	2012-07-23	2014-12-23	Knaack Llc	Jobsite storage cabinet for housing electronic equipment
WO2015066292A1 (en)	2013-11-01	2015-05-07	Merial Limited	Attenuated pasteurella multocidavaccines & methods of making & use thereof
CN107075562B (zh) *	2014-09-30	2021-09-24	深圳华大基因科技有限公司	用于肥胖症相关疾病的生物标记物
TW202214294A (zh) *	2020-09-30	2022-04-16	美商碩騰服務公司	具有ｈｙａＣ及ｎａｎＰ缺失之新穎多殺性巴斯德氏菌株及疫苗
TW202219269A (zh) *	2020-09-30	2022-05-16	美國農業部	新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0668779A4 (en) *	1992-11-06	1996-08-21	Univ Minnesota	Vaccine to protect against pasteurellosis - infection by P.multocida.
US6793927B1 (en) *	1993-12-06	2004-09-21	The United States Of America As Represented By The Secretary Of The Department Of Agriculture	Construction of Pasteurella haemolytica vaccines
DK0796341T3 (da)	1994-12-09	1999-06-14	Imp College Innovations Ltd	Identifikation af gener, som tillader tilpasning af en mikroorganisme til en særlig omgivelse
CA2206575A1 (en) *	1996-05-31	1997-11-30	Akzo Nobel Nv	Live attenuated rtx-producing bacteria of the family pasteurellaceae
US6086894A (en) *	1996-06-27	2000-07-11	Virginia Tech Intellectual Properties, Inc.	Recombinant vaccine for diseases caused by encapsulated organisms
US6783764B1 (en) *	1997-04-10	2004-08-31	Akzo Nobel Nv	Actinobacillus pleuropneumoniae subunit vaccine
CH692179A5 (de)	1997-06-25	2002-03-15	Kueschall Design Ag	Rollstuhl und Sitzmodul für den Rollstuhl,
US20010018055A1 (en) *	1997-09-25	2001-08-30	Briggs Robert E.	Deletion mutants of virulence factors of pasteurellaceae
BR0009663A (pt)	1999-04-09	2002-04-09	Upjohn Co	Composições de vacinas antibacterianas
US6790950B2 (en) *	1999-04-09	2004-09-14	Pharmacia & Upjohn Company	Anti-bacterial vaccine compositions
GB9910812D0 (en) *	1999-05-10	1999-07-07	Microscience Ltd	Vaccine composition
US6780405B1 (en) *	2000-04-28	2004-08-24	Avant Immunotherapeutics, Inc.	Regulated antigen delivery system (RADS)
WO2002018601A2 (en) *	2000-08-25	2002-03-07	Abbott Laboratories	Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes'
US20040029129A1 (en) *	2001-10-25	2004-02-12	Liangsu Wang	Identification of essential genes in microorganisms
ATE470674T1 (de) *	2002-04-05	2010-06-15	Merial Sas	Abgeschwächte gramnegative bakterien
US7449178B2 (en)	2002-04-05	2008-11-11	Merial Limited	Attenuated gram negative bacteria
CA2520386A1 (en) *	2003-03-27	2004-10-14	Children's Hospital, Inc.	Nontypeable haemophilus influenzae virulence factors
UA100370C2 (uk) *	2006-12-11	2012-12-25	Мериал Лимитед	Спосіб вакцинації птахів проти salmonella
TWI328458B (en) *	2007-03-09	2010-08-11	Univ Nat Chunghsing	Subunit vaccine of pasteurella multocida in veterinary uses

2003
- 2003-04-03 US US10/406,686 patent/US7449178B2/en not_active Expired - Lifetime
- 2003-04-04 PT PT03719577T patent/PT1575483E/pt unknown
- 2003-04-04 CN CN2011104311167A patent/CN102864090A/zh active Pending
- 2003-04-04 NZ NZ535993A patent/NZ535993A/en not_active IP Right Cessation
- 2003-04-04 CN CNA038123800A patent/CN1934240A/zh active Pending
- 2003-04-04 WO PCT/US2003/010308 patent/WO2003086277A2/en active Application Filing
- 2003-04-04 CA CA2481186A patent/CA2481186C/en not_active Expired - Lifetime
- 2003-04-04 AT AT03719577T patent/ATE518955T1/de active
- 2003-04-04 EP EP03719577A patent/EP1575483B1/en not_active Expired - Lifetime
- 2003-04-04 AU AU2003223447A patent/AU2003223447C1/en not_active Expired
- 2003-04-04 ES ES03719577T patent/ES2371498T3/es not_active Expired - Lifetime
- 2003-04-04 BR BRPI0309001-9A patent/BRPI0309001B1/pt not_active IP Right Cessation
- 2003-04-04 MX MXPA04009730A patent/MXPA04009730A/es active IP Right Grant
- 2003-04-04 KR KR1020047015890A patent/KR101037566B1/ko active IP Right Grant
- 2003-04-04 JP JP2003583304A patent/JP4338528B2/ja not_active Expired - Lifetime
2004
- 2004-11-04 CO CO04111105A patent/CO5640065A1/es not_active Application Discontinuation
2005
- 2005-12-02 HK HK05111055.4A patent/HK1078271A1/xx not_active IP Right Cessation
2008
- 2008-10-07 US US12/246,809 patent/US7943125B2/en not_active Expired - Lifetime
2010
- 2010-08-04 AU AU2010206113A patent/AU2010206113B2/en not_active Expired
2011
- 2011-04-20 US US13/091,046 patent/US8329163B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20040033586A1 (en)	2004-02-19
WO2003086277A9 (en)	2006-02-23
JP4338528B2 (ja)	2009-10-07
ATE518955T1 (de)	2011-08-15
US7449178B2 (en)	2008-11-11
BRPI0309001A2 (pt)	2017-07-04
US20090252766A1 (en)	2009-10-08
EP1575483A2 (en)	2005-09-21
HK1078271A1 (en)	2006-03-10
US7943125B2 (en)	2011-05-17
US8329163B2 (en)	2012-12-11
KR101037566B1 (ko)	2011-05-27
CN1934240A (zh)	2007-03-21
NZ535993A (en)	2010-02-26
WO2003086277A3 (en)	2007-03-01
CA2481186C (en)	2015-10-06
BRPI0309001B1 (pt)	2021-11-30
AU2010206113A1 (en)	2010-08-26
AU2010206113B2 (en)	2012-03-15
KR20050016334A (ko)	2005-02-21
AU2003223447A1 (en)	2003-10-27
CA2481186A1 (en)	2003-10-23
US20120009218A1 (en)	2012-01-12
CO5640065A1 (es)	2006-05-31
AU2003223447B2 (en)	2010-06-03
AU2003223447C1 (en)	2011-01-06
ES2371498T3 (es)	2012-01-03
MXPA04009730A (es)	2006-04-28
EP1575483B1 (en)	2011-08-03
JP2005535296A (ja)	2005-11-24
EP1575483A4 (en)	2007-07-04
WO2003086277A2 (en)	2003-10-23
CN102864090A (zh)	2013-01-09

Publication	Publication Date	Title
HK1078271A1 (en)	2006-03-10	Attenuated gram negative bacteria
DE60310264D1 (en)	2007-01-18	Thermostabile alpha-amylase
MX9705727A (es)	1997-11-29	Variantes de amilasa.
GEP20032977B (en)	2003-05-27	Proteinase K-Resistant Surface Protein of Neisseria Meningitidis
AU2002345084A1 (en)	2003-03-03	Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene
NZ549873A (en)	2008-06-30	Compounds and methods for treatment and diagnosis of chlamydial infection by stimulating an immune response
IL175319A0 (en)	2006-09-05	Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
NO960839D0 (no)	1996-02-29	Bakterieeksporterte proteiner og acellulære vaksiner som er basert derpå
IL162917A0 (en)	2005-11-20	A lysin from bacteriophage and pharmaceutical compositions containing the same
ES2535961T3 (es)	2015-05-19	Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
CY1108972T1 (el)	2014-07-02	Εξασθενημενα αρνητικα κατα gram βακτηρια
EP1302537A4 (en)	2004-05-26	Novel glucose-6-phosphate dehydrogenase
ZA985393B (en)	1999-02-17	Clostridium perfringens vaccine
HU0004877D0 (pt)	2001-02-28
BR9506038A (pt)	1997-10-07	Dna clonato vetor recombinante e planta
EP1476462A4 (en)	2005-09-28	NEW LIPASE FROM MUSHROOMS
KR930013104A (ko)	1993-07-21	세르풀리나 하이오다이센테리애 백신
MX9603876A (es)	1997-03-29	Procedimiento intermitente de digestion para producir pulpa deslignficada.
NZ511166A (en)	2002-11-26	Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B
NO20025126L (no)	2002-12-20	(R)-2-hydroksy-3-fenylpropionisk syre (D-fenylmelkesyre) dehydrogenase, oggen som koder for samme
WO2003104441A3 (en)	2004-03-25	NOVEL BACTERIAL STRAIN, COMPOSITIONS DERIVED THEREFROM AND METHODS OF USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BETA-AMYLOID PEPTIDE (DOLLAR G (B) AP)
TH53371B (th)	2002-10-07	ลำดับนิวคลิโอไทด์ใหม่ซึ่งใส่รหัสสำหรับจีน cls
EP1158052A4 (en)	2002-10-02	BETA-PRIMEVEROSIDASDE GENE
GB9027901D0 (en)	1991-02-13	Acellular vaccine
WO2000046242A3 (en)	2000-11-23	19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI)